Effects of Respiratory Proprioceptive Neuromuscular Facilitation (PNF) Technique on Pulmonary Function of Chronic Pulmonary Obstructive Disease (COPD) Patients.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COPD
- Sponsor
- Riphah International University
- Enrollment
- 56
- Locations
- 1
- Primary Endpoint
- Forced expiratory volume in 1sec (FEV1)
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The purpose of this study is to evaluate the impact of PNF technique combined with aerobic exercises among COPD patients in a clinical setting. Previous literature has evaluated this technique in ventilated patients but in clinical setting specifically in Pakistan, this invention therapy has not been implied in COPD patients.
Detailed Description
Chronic Obstructive Pulmonary Disorder manifested as breathlessness, respiratory difficulties and persistent cough is one of the biggest causes of mortality around the world. 2.1% of Pakistani population has COPD. Proprioceptive neuromuscular facilitation is used as management technique in which muscle stretching promotes chest wall mobility and restores regular breathing rhythm. In previous studies, PNF technique combined with aerobic exercises has been utilized to improve Pulmonary functions in COPD patients. But the sample size of these studies was small and participants were ventilated patients, hence not targeting the diaphragm. Our study shall evaluate the impact of PNF technique combined with aerobic training on the Pulmonary function of COPD patients in the clinical setting.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Both male \& female participants.
- •Diagnosed COPD patients
- •Age 35-60years
- •Ratio of forced expiratory volume in first second \& forced vital capacity(FEV1/FVC \<0.7,30%\<FEV1\<80%
- •Stable clinical condition.
Exclusion Criteria
- •Serious conditions with require supplementary oxygen or ventilator/support devices.
- •COPD exacerbation within last 4weeks
- •Patients with recent chest wall trauma, surgery or deformity.
- •Patient with neurological, psychological, musculoskeletal, or cardiac medical history.
- •Pulmonary disease with physical impairment.
- •Inability to follow the pulmonary rehabilitation program.
Outcomes
Primary Outcomes
Forced expiratory volume in 1sec (FEV1)
Time Frame: two weeks
Forced expiratory volume in 1sec (FEV1) measured through digital spirometer. If the value of FEV1 is within 80% of the reference value, the results are considered normal
Chest Expansion
Time Frame: two weeks
The expansion of chest during breathing will be measures and axillary, nipple and xiphisternal level using a measuring tape.
Modified Borg Dyspnea Scale
Time Frame: two weeks
Participants will fill this 12 points Scale to show breathing difficulty from 0 to 10.
COPD assessment test
Time Frame: two weeks
8 points questionnaire will evaluate patients Pulmonary function capacity through semantic 6 point difference Scale.
Peak expiratory flow rate (PEFR)
Time Frame: two weeks
Peak expiratory flow rate (PEFR) Peak expiratory flow rate (PEFR) measured through digital spirometer. Peak Expiratory Flow Rate (PEFR) measured through digital spirometer. Three zones of measurement are commonly used to interpret peak flow rates. Normal value of PEFR is (80-100%). Green zone indicates 80 to 100 percent of the usual or normal peak flow reading, yellow zone indicates 50 to 79 percent of the usual or normal peak flow readings, and red zone indicates less than 50 percent of the usual or normal peak flow readings.
Forced vital capacity (FVC)
Time Frame: two weeks
Forced vital capacity (FVC) measured through digital spirometer. If the value of FVC is within 80% of the reference value, the results are considered normal. Changes in FVC from baseline to 5th and after 15th day of intervention will be assessed.
Secondary Outcomes
- 6 minutes walk test:(two weeks)